Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
30 hedge funds and large institutions have $105M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
22% more capital invested
Capital invested by funds: $85.5M → $105M (+$19.1M)
9% less funds holding
Funds holding: 33 → 30 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
81% less call options, than puts
Call options by funds: $328K | Put options by funds: $1.73M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$8.89M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$7.34M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$5.2M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$4.32M |
| 5 |
PC
PointState Capital
New York
|
+$2.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$579K |
| 2 |
Renaissance Technologies
New York
|
-$231K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$137K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$128K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$114K |
CORV Hedge Fund Activity: Q3 2015 in Review
30 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2015, worth a combined $105M — up 22% from $85.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CORV and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 12 added.
The largest buyer was Putnam Investments, adding an estimated $8.89M. The largest seller was Group One Trading, cutting an estimated $579K.
- 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2015, down from 33 in Q2 2015.
- Funds reported $105M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2015, up 22% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2015 and 7 closed out, a net change of -3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2015 was Putnam Investments, an estimated $8.89M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2015 was Group One Trading, an estimated $579K sold.
Based on aggregated 13F filings for Q3 2015.